Epratuzumab (Anti-Siglec-2 / CD22), 1mg*5

Epratuzumab (Anti-Siglec-2 / CD22), 1mg*5

Anti-Siglec-2 / CD22 (NCI m971), 1mg

Anti-Siglec-2 / CD22 (NCI m971), 1mg

Epratuzumab (Anti-Siglec-2 / CD22), 1mg*25

19.336,31 RON
SKU
SKM_A3056_1mg*25

Epratuzumab (Anti-Siglec-2 / CD22) is a IgG1 monoclonal antibody targeting CD22. It has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases. MW: 155.4 KD.

Mai multe informatii
Price 16.249,00 RON (preturile sunt fara TVA)
Description

Epratuzumab (Anti-Siglec-2 / CD22) is a IgG1 monoclonal antibody targeting CD22. It has been used to research non-Hodgkin’s lymphomas (NHL) and certain autoimmune diseases. MW: 155.4 KD.